Literature DB >> 5481705

Radioimmunoassay for serum digitoxin concentration: methodology and clinical experience.

T W Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5481705

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  12 in total

1.  THE MEASUREMENT OF CARDIAC GLYCOSIDE CONCENTRATIONS.

Authors:  Linda Monroe; John A. Burdine
Journal:  Cardiovasc Dis       Date:  1974

2.  Clinical pharmacokinetics of digitoxin.

Authors:  D Perrier; M Mayersohn; F I Marcus
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

Review 3.  Digitalis intoxication.

Authors:  E K Chung
Journal:  Postgrad Med J       Date:  1972-03       Impact factor: 2.401

Review 4.  [Determination of digoxin and digitoxin in the blood and their clinical significance].

Authors:  G Bodem; H J Gilfrich
Journal:  Klin Wochenschr       Date:  1973-01-15

5.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

6.  Pharmacokinetics and pharmacodynamics of intravenous digoxin and digitoxin.

Authors:  H R Ochs; E Grube; D J Greenblatt; R Arendt; G Bodem
Journal:  Klin Wochenschr       Date:  1981-08-17

7.  Anaesthetic problems associated with the treatment of cardiovascular disease: I. Digitalis toxicity.

Authors:  D C Chung
Journal:  Can Anaesth Soc J       Date:  1981-01

8.  Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.

Authors:  H R Ochs; T W Smith
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

9.  Ouabain-specific antibodies: immunochemical properties and reversal of Na + , K + -activated adenosine triphosphatase inhibition.

Authors:  T W Smith
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

10.  Measurement of plasma glycoside level following pengitoxin administration.

Authors:  K O Haustein
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.